Related Experiment Video
Updated: Sep 20, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
[Creatine kinase BB activity in the serum of patients with cerebrovascular diseases]
Insights
Serum creatine kinase BB isoenzyme (CK-BB) levels increase significantly with the severity of cerebrovascular disease lesions. Severe lesions showed peak CK-BB activity on day one post-symptoms, indicating its potential as a biomarker.
Area of Science:
- Biochemistry
- Neurology
- Medical Diagnostics
Context:
- Conflicting reports exist regarding creatine kinase BB isoenzyme (CK-BB) activity in cerebrovascular disease.
- Accurate assessment of CK-BB levels is crucial for understanding its role in neurological conditions.
Purpose:
- To investigate the correlation between serum CK-BB activity and the extent of brain lesions in patients with cerebrovascular disease.
- To clarify the diagnostic utility of CK-BB in differentiating lesion severity.
Summary:
- Serum CK-BB activity was measured in 33 patients with ischemic brain infarction, subarachnoid hemorrhage, or intracerebral hemorrhage using a bioluminescence method and immunoprecipitation.
- A significant elevation in CK-BB activity was observed in patients with more extensive and severe brain lesions compared to controls.
- Patients with severe lesions exhibited peak CK-BB activity on the first day following symptom onset.
Impact:
- This study provides evidence that elevated serum CK-BB levels are associated with the severity of cerebrovascular lesions.
- Findings suggest CK-BB may serve as a valuable biomarker for assessing the extent of brain damage in cerebrovascular events.
- The temporal profile of CK-BB elevation, particularly its peak on day one in severe cases, offers insights for clinical monitoring.
Abstract:
There are conflicting reports of an increase in the activity of creatine kinase BB isoenzyme (CK-BB) in the serum of patients with cerebrovascular disease. The serum CK-BB activity of 33 patients with ischemic brain infarction, subarachnoid hemorrhage or intracerebral hemorrhage was measured with a bioluminescence method (CK-B Kit, LKB-Wallac) in combination with immunoprecipitation. The results were compared with lesions determined by computed tomography. In the control group (N = 19) there was a mean activity of 0.35 +/- 0.26 U/l (means +/- SE). In patients with small lesions (N = 11) the activity was 0.41 +/- 0.21 U/l, which was not significantly elevated when compared to the control group (Mann/Whitney U test). Therefore, patients with more extensive lesions (N = 12) and the group with severe lesions (N = 10) showed a significant elevation, with a mean activity of 0.61 +/- 0.34 U/l and 1.12 +/- 0.52 U/l, respectively. The group with severe lesions had a maximum activity on the first day after the initial symptoms.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

